Pharmaceutical composition for treating irritable bowel syndrome and preparation method thereof

The invention provides a pharmaceutical composition for treating irritable bowel syndrome and a preparation method thereof, and belongs to the field of pharmaceutical preparations. It is found for the first time that the composition obtained by combining SMP-100 and auxiliary materials including lactose monohydrate, microcrystalline cellulose, pregelatinized starch, hydroxypropyl methylcellulose, croscarmellose sodium, magnesium stearate, colloidal silicon dioxide, polyvinylpolypyrrolidone and low-substituted hydroxypropyl cellulose is excellent in stability and suitable for being prepared into a pharmaceutical preparation. According to the pharmaceutical composition provided by the invention, the compatibility of the auxiliary materials and the SMP-100 is good, and the stability of the obtained preparation is excellent. Moreover, the pharmaceutical composition is simple in preparation method, easy to realize industrial production and wide in application prospect..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 30. Mai Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

HUANG JINKUN [VerfasserIn]
XIE DEJIAN [VerfasserIn]
DENG FENGYING [VerfasserIn]
CAO CHENGMIN [VerfasserIn]
LI PEI [VerfasserIn]
WU CHENGLONG [VerfasserIn]
WANG MIN [VerfasserIn]
HU FEI [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-05-30, Last update posted on www.tib.eu: 2023-11-07, Last updated: 2023-11-10

Patentnummer:

CN116173039

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA01842807X